FGFR1OP antibody (AA 341-390)

Catalog No. ABIN2889194

Product Details anti-FGFR1OP Antibody

Target: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Binding Specificity: AA 341-390

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FGFR1OP antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificity: FGFR1 Oncogene Partner Antibody detects endogenous levels of total FGFR1 Oncogene Partner protein.

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide from human FGFR1 Oncogene Partner (aa341-390).

Type of Immunogen: Synthetic peptide

Isotype: IgG

Application Details

Application Notes: Approved: IHC, IHC-P, Peptide-ELISA (1:10000), WB (1:500 - 1:1000)

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS (without Mg2+, Ca2+),  pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for up to 1 year.

Expiry Date: 12 months

Target Details for FGFR1OP

Target: FGFR1OP (FGFR1 Oncogene Partner (FGFR1OP))

Alternative Name: FGFR1OP / FOP (FGFR1OP Products)

Synonyms: 4930553O10Rik antibody, FOP antibody, ccr6a antibody, zgc:86782 antibody, fgfr1op antibody, Fgfr1op antibody, MGC132198 antibody, C1orf77 antibody, C3H1orf77 antibody, SRAG antibody, Fgfr1 oncogene partner antibody, FGFR1 oncogene partner antibody, FGFR1 oncogene partner L homeolog antibody, chromatin target of PRMT1 antibody, Fgfr1op antibody, FGFR1OP antibody, fgfr1op antibody, fgfr1op.L antibody, CHTOP antibody

Background: Name/Gene ID: FGFR1OP

Synonyms: FGFR1OP, FOP, FGFR1 oncogene partner

Gene ID: 11116

UniProt: O95684

Pathways: M Phase, Maintenance of Protein Location, SARS-CoV-2 Protein Interactome